Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
Treament | Trials | |||||
---|---|---|---|---|---|---|
clinical deterioration | clinical improvement | deaths | viral clearance | |||
anticoagulant | - | - | OBS 0.89 [0.63; 1.25], 9 studies, I2=92% inconclusive result | - | ||
face mask | 0 | - | - | - | - | |
febuxostat | 0 | - | - | - | - | |
hydrogen-oxygen nebulizer | 0 | - | - | - | - | |
hyperbaric oxygen | 0 | - | - | - | - | |
nintedanib | 0 | - | - | - | - | |
paracetamol | 0 | - | - | - | - | |
pulmonary rehabilitation | 0 | - | - | - | - | |
respiratory support | 0 | - | - | - | - |